source
- AstraZeneca launches $1.5 billion annual cost-saving plan to offset late-stage trial setbacksAstraZeneca announced a new cost‑saving initiative targeting $1.5 billion of annual expenses. The move follows a series of late‑stage clinical trial failures that have pressured the company's pipe…
- FDA rolls out new inspection coordination plan, lifts estradiol patch warning and HHS permits compounding of six peptidesFDA's drug center and inspections office have agreed on a new concept of operations (ConOps) to better coordinate inspections and compliance activities. A U.S. senator introduced draft legislation…